Latest by Sony Salzman
Despite the diversity of new direct-acting antivirals (DAAs), a tiny number of patients are still left behind. Nancy Reau, M.D., presented a summary of soon-to-be-approved drugs that should work for these tough-to-treat patients.
State Medicaid Programs Ease Illegal Restrictions on Hepatitis C Medications, but More Progress Needed
While restrictions for obtaining hepatitis C drugs through Medicaid programs vary state by state, restrictions eased somewhat across the country from 2014 to 2016, according to data presented at the Liver Meeting 2016.
A health program called Project ECHO successfully used telecommunication technology to coach local care providers on how to treat hepatitis C in New Mexico. Now its founder wants to expand the program to the rest of the world and all primary care....
A staggering 38% of new HIV infections among low-income women in the U.S. may be due to anal intercourse, which is poorly understood in women, according to a study presented at HIVR4P 2016.
Like other viruses, hepatitis C has evolved into distinct subgroups, which has made the virus difficult to treat with a universal drug. Here is a review of the main genotypes, where they are found and how to treat them.
Should HIV Cure Research, Inspired by Advances in Fighting Cancer, Aim for Remission Not Eradication?
While a true cure remains elusive for both diseases, HIV researchers are looking at new advances in immuno-oncology for clues on how to achieve durable HIV remission.
In this interview, Carl Dieffenbach, Ph.D., director of the Division of AIDS, National Institute of Allergy and Infection Diseases (NIAID), shares his thoughts on the challenges and opportunities ahead on the road toward an HIV cure.
When it comes to clinical trials for HIV cures, many patient volunteers may be asked to stop taking their once-daily medicines to measure the true effect of the experimental treatment, raising ethical questions and concerns.
Even with hepatitis C cures available, many health care providers are still caring for patients who must wait for months to start treatment. Here's how to help patients who may experience flu-like symptoms while they wait.
Working as an HIV provider is definitely not a stress-free job. "Burnout does happen over time. Providers need to really take care of themselves, take time out and connect with others," said Laura Cheever, M.D.